† Age standardised rates (per 100,000) The tables and figures presented in this paper show results stratified by year (1990 90 and 2000 02); however, to explore the interaction between year and deprivation we modelled the unstratified data.
Nevertheless, spousal studies are possible with the available data.
Furthermore, there were concerns about the applicability of the studies, as unstratified data for different applied D-dimer assays (enzyme linked fluorescent assays as well as quantitative latex assays) within one study cohort was presented for six of the 13 study cohorts.
These data suggest no increased risk of epoetin- β treatment on overall survival in patients whose baseline haemoglobin was ⩽10 g dl−1 (HR=0.95, 95% CI 0.72; 1.16) or ⩽11 g dl−1 (HR=1.03, 95% CI 0.85; 1.25), which was consistent with the unstratified analysis (HR=1.13, 95% CI 0.98; 1.31, log-rank P-value=0.082).
However, there was no indication for an increased risk of mortality, disease progression or TEEs in patients achieving maximum Hb levels >13 g dl−1 (HR=0.79, 1.08 and 1.32, respectively) when compared with the unstratified analyses.
To gain deeper insight into the nature of the observed relation between hypernatremia and mortality in the presence of CDI, we computed a measurement to explain variation in survival time (namely, R), which is appropriate for use with the unstratified Cox regression models with time-dependent covariates.
To observe the impact of Tweet similarity between the training and testing set, we examined the performance with (r=0.75) and (r=0.9) and compared these against the unstratified (complete) training data.
Where possible, the new data were compared with existing data from the literature, with good agreement.
The second MTHFR genotype, A1298C, was significantly associated with survival in the unstratified analysis (Table 5).
C677T was not significantly associated with breast cancer survival in the unstratified Cox regression analysis with adjustments for age at diagnosis, race, A1298C, body mass index (BMI), ER status, TNM stage, and chemotherapy (Table 4).
